Arista said fourth-quarter revenue increased 20.8% year-over-year to $1.54 billion, which beat the consensus estimate of $1.53 billion, according to Benzinga Pro. The company reported quarterly earnings of $2.08 per share, which beat analyst estimates of $1.70 per share.
Moderna, Inc (NASDAQ:MRNA) and Merck & Company, Inc’s (NYSE:MRK) cancer vaccine exhibited positive results against relapse for melanoma patients, results from a midstage…
https://friendlybearresearch.com/2023/07/26/b-riley-may-face-fallout-from-applied-digital-governance-problems/
Recent developments suggest that B. Riley is controlling managerial decisions at Applied Digital to the